News

The Pirbright Institute joins the nation and rest of the world in mourning the loss of Her Majesty Queen Elizabeth II. For more than seven decades she dedicated herself to public service, and inspired others globally. Prof Bryan Charleston, Director of The Pirbright Institute said “Her majesty was a…

Seven of Pirbright’s scientists have had upcoming projects funded by UKRI through the BBSRC Impact Acceleration Account (IAA). These scientists have several qualities in common: scientific know-how, experience in leading projects, and the fact they are all women. The IAA helps scientists create…

Researchers at The Pirbright Institute have developed a potential vaccine for infectious bronchitis virus (IBV) that could protect chickens from severe disease with just one dose. IBV is a coronavirus that causes a highly contagious disease in poultry, it results in respiratory symptoms and affects…

Pirbright joins a consortium of six institutes to receive funding of £1.6 million to support collaborative research against infectious diseases. The consortium, which sees world-leading experts from Pirbright, the Liverpool School of Tropical Medicine, UK Health Security Agency, London School of…

African swine fever is a highly contagious disease caused by the African swine fever virus. It infects both domestic and wild pigs and has a case fatality rate of up to 100%. There have been outbreaks in Europe in recent years, with the latest near the French border in Germany, bringing this disease…

Pirbright has been awarded £100,000 to support innovative research and promote knowledge exchange. This funding was given by UK Research and Innovation (UKRI) in its Impact Acceleration Account (IAA) which aims to support early-stage translation of UK research to have real-life impact. Following an…

Pirbright research shows that immunity to SARS-CoV-2, the virus that causes COVID-19, decreases over time after vaccination, but that booster vaccinations can help restore immunity and help the immune system recognise new variants of the virus, including Omicron. Vaccination against SARS-CoV-2 has…

Pirbright was one of just 16 exhibits selected to attend the prestigious Royal Society Summer Science Exhibition 2022 which showcased cutting-edge science for people of all ages. Pirbright’s exhibit, titled ‘Disease Detectives’ explained what scientists and detectives have in common, and why…

The Institute is partnering with Nurole, the leading board-level hiring platform, to find two new Trustee Directors to join its Board. One will be a high-achieving bio-scientist, ideally in the fields of virology or immunology, and who will be a leader in their discipline, bring senior strategic…

Pirbright’s insectary facilities are among the best in the world. They allow us to research vector-borne viral diseases, including those spread by midges, mosquitoes, and flies. Vector-borne viral diseases such as Rift Valley fever virus and bluetongue virus have devastating effects on human and…

Pirbright researchers are set to join forces with some of the UK’s top experts in avian influenza in a new research consortium dedicated to tackling bird flu. This consortium has received £1.5 million from the Biotechnology and Biosciences Research Council (BBSRC) and the Department of Environment…

Last week Pirbright celebrated the success of two of our apprentices, Lucy Drudge and Alex Reeves, both of whom completed their apprenticeship programme earlier this year and have gone on to secure positions at the Institute. Lucy is currently working in the Grants Office and Alex in BACS (Building…